Clinical Trial Update: Clinical Study of OR for Second-line Treatment of Refractory MZL [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the OR Regimen for relapsed/refractory marginal zone lymphoma is currently recruiting. This study investigates a second-line treatment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marginal Zone Lymphoma

Drugs mentioned

• OR Regimen

Snippet

Sponsor: Lixia Sheng | Conditions: OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma | Phase 4 | Status: RECRUITING